Cargando…
Asthma-related outcomes during the SARS-CoV2 pandemic: A single-center observational study
Autores principales: | Al-Hazaymeh, Amani, Patrie, James, Adams, Jason C., Borish, Larry, McGowan, Emily C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Academy of Allergy, Asthma & Immunology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8225608/ https://www.ncbi.nlm.nih.gov/pubmed/34144223 http://dx.doi.org/10.1016/j.jaip.2021.05.034 |
Ejemplares similares
-
Eosinophils in antiviral immunity and (perhaps) a benefit of having asthma during the SARS-CoV2 pandemic
por: Eid, Ryan, et al.
Publicado: (2021) -
Th2 cytokines and asthma — Interleukin-4: its role in the pathogenesis of asthma, and targeting it for asthma treatment with interleukin-4 receptor antagonists
por: Steinke, John W, et al.
Publicado: (2001) -
Association between Cystic Fibrosis exacerbations, lung function, T2 inflammation and microbiological colonization
por: Albon, Dana, et al.
Publicado: (2023) -
The past, present, and future of monoclonal antibodies to IL-5 and eosinophilic asthma: a review
por: Patterson, Megan F, et al.
Publicado: (2015) -
Assessment of asthma control and asthma exacerbations in the epidemiology and natural history of asthma: outcomes and treatment regimens (TENOR) observational cohort
por: Chipps, Bradley E., et al.
Publicado: (2012)